Prevention of transfusion-acquired CMV infection: is there a role for NAT?
- 12 March 2003
- journal article
- Published by Wiley in Transfusion
- Vol. 43 (3) , 302-305
- https://doi.org/10.1046/j.1537-2995.2003.00373.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipientsTransfusion, 2003
- CMV DNA is rarely detected in healthy blood donors using validated PCR assaysTransfusion, 2003
- Human Cytomegalovirus DNA in Plasma and Serum Specimens of Renal Transplant Recipients Is Highly FragmentedJournal of Clinical Microbiology, 2002
- High frequency of human cytomegalovirus (HCMV)-specific CD8 + -T cells detected in a healthy CMV-seropositive donorCellular and Molecular Life Sciences, 2002
- Latency and Reactivation of Human CytomegalovirusJournal of Infection, 2002
- Multicenter evaluation of PCR methods fordetecting CMV DNA in blood donorsTransfusion, 2001
- The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration methodsBlood, 2001
- The cytomegalovirus-“safe” blood product: Is leukoreduction equivalent to antibody screening?Transfusion Medicine Reviews, 2000
- Human Cytomegalovirus Reactivation in Bone-Marrow-Derived Granulocyte/Monocyte Progenitor Cells and Mature MonocytesIntervirology, 1999